Drug Index


Mechanism :

Hydroxyzine is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system. Primary skeletal muscle relaxation has been demonstrated experimentally. Bronchodilator activity, and anti-histaminic and analgesic effects have been demonstrated experimentally and confirmed clinically.

Indication :

  • Urticaria
  • Pruritus
  • Anxiety- short term
  • Nausea and vomiting
  • Adjunct to anaesthesia/Preoperative sedation

Contraindications :

Hydroxyzine is contraindicated for patients who have shown a previous hypersensitivity to it and in early pregnancy. Use with caution in patients with impaired renal function since it is uncertain whether the drug may accumulate or have other adverse effects in such patients. Avoid in patients with acute porphyria.

Dosing :

Pruritis, nausea, vomiting:
<6 years of age;
50 mg/day in four divided oral doses.
>6 years of age:
50-100 mg in four divided oral doses.
Preoperative sedation:
0.6 mg/kg given orally or 0.5-1.1 mg/kg IM.

Adverse Effect :

Drowsiness, dry mouth, weakness, headache, dizziness, confusion, tremor and convulsions.

Interaction :

Narcotics, Non-Narcotic Analgesics and Barbiturates: Potentiating action of hydroxyzine must be considered. Therefore, when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Start with small dose, e.g. 25 mg at night and increase to 2–3 times a day if necessary
<10Start with small dose, e.g. 25 mg at night and increase to 2–3 times a day if necessary

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in GFR<10 mL/min
HDNot dialysed. Dose as in GFR<10 mL/min
HDF/High fluxNot dialysed. Dose as in GFR<10 mL/min
CAV/VVHDNot dialysed. Dose as in GFR=10– 20 mL/min

Hepatic Dose :

Mild – Moderate hepatic impairment: The total daily dose should be reduced by one-third.
Severe hepatic impairment: Avoid use.
12/24/2023 08:21:50 Hydroxyzine
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0